NantKwest Stock Price - NK

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NantKwest Inc NK NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.02 1.49% 1.36 1.39 1.34 1.34 1.34 18:00:10
Bid Price Ask Price Spread Spread % News
1.03 2.00 0.97 48.5% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
422 84,355 $ 1.37 $ 115,402 101,003 0.93 - 4.23
Last Trade Time Type Quantity Stock Price Currency
16:00:00 1,603 $ 1.36 USD

NantKwest Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 133.70M 98.31M $ -96.23M -1.22 - 93.79M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

NantKwest News

Loading Messages....

Latest NK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NK Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week1.351.41.291.346798k0.010.74%
1 Month1.
3 Months1.11.551.011.1845218k0.2623.64%
6 Months1.221.86960.951.3057401k0.1411.48%
1 Year2.914.230.931.8605412k-1.55-53.26%
3 Years9.339.59990.933.6975323k-7.97-85.42%
5 Years3738.480.937.7538357k-35.64-96.32%

NantKwest Description

NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S. territories.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.